Open Access
Numéro
Med Sci (Paris)
Volume 41, Numéro 2, Février 2025
Page(s) 121 - 124
Section Nouvelles
DOI https://doi.org/10.1051/medsci/2025004
Publié en ligne 3 mars 2025
  1. Martin SS, Aday AW, Almarzooq ZI, et al. 2024 heart disease and stroke statistics: A report of US and global data from the American Heart Association. Circulation 2024 ; 149 : e347–e913. [PubMed] [Google Scholar]
  2. Jenča D, Melenovský V, Stehlik J, et al. Heart failure after myocardial infarction: incidence and predictors. ESC Heart Fail 2021 ; 8 : 222–37. [CrossRef] [PubMed] [Google Scholar]
  3. Sahara M, Santoro F, Chien KR. Programming and reprogramming a human heart cell. EMBO J 2015 ; 34 : 710–38. [CrossRef] [PubMed] [Google Scholar]
  4. Damluji AA, van Diepen S, Katz JN, et al. Mechanical complications of acute myocardial infarction: A scientific statement from the American Heart Association. Circulation 2021 ; 144 : e16–e35. [CrossRef] [PubMed] [Google Scholar]
  5. Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 2017 ; 377 : 1119–31. [CrossRef] [PubMed] [Google Scholar]
  6. Bhatt DL, Steg PG, Miller M, et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med 2019 ; 380 : 11–22. [CrossRef] [PubMed] [Google Scholar]
  7. Bacar H, Michallet MC. La voie cGAS-STING : une nouvelle arme « innée » contre le cancer. Med Sci (Paris) 2021 ; 37 : 677–80. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  8. Sun L, Wu J, Du F, et al. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 2013 ; 339 : 786–91. [CrossRef] [PubMed] [Google Scholar]
  9. Ishikawa H, Ma Z, Barber GN. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 2009 ; 461 : 788–92. [CrossRef] [PubMed] [Google Scholar]
  10. Sheehan KCF, Lai KS, Dunn GP, et al. Blocking monoclonal antibodies specific for mouse IFN-α/β receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection. J Interferon Cytokine Res 2006 ; 26 : 804–19. [CrossRef] [PubMed] [Google Scholar]
  11. Decout A, Katz JD, Venkatraman S, et al. The cGAS-STING pathway as a therapeutic target in inflammatory diseases. Nat Rev Immunol 2021 ; 21 : 548–69. [CrossRef] [PubMed] [Google Scholar]
  12. King KR, Aguirre AD, Ye Y-X, et al. IRF3 and type I interferons fuel a fatal response to myocardial infarction. Nat Med 2017 ; 23 : 1481–7. [CrossRef] [PubMed] [Google Scholar]
  13. Ninh VK, Calcagno DM, Yu JD, et al. Spatially clustered type I interferon responses at injury borderzones. Nature 2024 ; 633 : 174–81. [CrossRef] [PubMed] [Google Scholar]
  14. Hieda M, Sarma S, Hearon CM, et al. Increased myocardial stiffness in patients with high-risk left ventricular hypertrophy: The hallmark of stage-B heart failure with preserved ejection fraction. Circulation 2020 ; 141 : 115–23. [CrossRef] [PubMed] [Google Scholar]
  15. Denais CM, Gilbert RM, Isermann P, et al. Nuclear envelope rupture and repair during cancer cell migration. Science 2016 ; 352 : 353–8. [CrossRef] [PubMed] [Google Scholar]
  16. Nava MM, Miroshnikova YA, Biggs LC, et al. Heterochromatin-driven nuclear softening protects the genome against mechanical stress-induced damage. Cell 2020 ; 181 : 800–17.e22. [CrossRef] [PubMed] [Google Scholar]
  17. Sladitschek-Martens HL, Guarnieri A, Brumana G, et al. YAP/TAZ activity in stromal cells prevents ageing by controlling cGAS-STING. Nature 2022 ; 607 : 790–8. [CrossRef] [PubMed] [Google Scholar]
  18. Honda S, Asaumi Y, Yamane T, et al. Trends in the clinical and pathological characteristics of cardiac rupture in patients with acute myocardial infarction over 35 years. J Am Heart Assoc 2014 ; 3 : e000984. [CrossRef] [PubMed] [Google Scholar]
  19. Humphrey JD, Dufresne ER, Schwartz MA. Mechanotransduction and extracellular matrix homeostasis. Nat Rev Mol Cell Biol 2014 ; 15 : 802–12. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.